Kitzmüller Claudia, Zulehner Nora, Roulias Anargyros, Briza Peter, Ferreira Fatima, Faé Ingrid, Fischer Gottfried F, Bohle Barbara
Christian Doppler Laboratory for Immunomodulation, Medical University of Vienna, Vienna, Austria; Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
J Allergy Clin Immunol. 2015 Jul;136(1):151-8. doi: 10.1016/j.jaci.2014.12.1928. Epub 2015 Feb 7.
Bet v 1 is the main sensitizing allergen in birch pollen. Like many other major allergens, it contains an immunodominant T cell-activating region (Bet v 1142-156). Api g 1, the Bet v 1 homolog in celery, lacks the ability to sensitize and is devoid of major T-cell epitopes.
We analyzed the T-cell epitopes of Mal d 1, the nonsensitizing Bet v 1 homolog in apple, and assessed possible differences in uptake and antigen processing of Bet v 1, Api g 1, and Mal d 1.
For epitope mapping, Mal d 1-specific T-cell lines were stimulated with overlapping synthetic 12-mer peptides. The surface binding, internalization, and intracellular degradation of Bet v 1, Api g 1, and Mal d 1 by antigen-presenting cells were compared by using flow cytometry. All proteins were digested with endolysosomal extracts, and the resulting peptides were identified by means of mass spectrometry. The binding of Bet v 1142-156 and the homologous region in Mal d 1 by HLA class II molecules was analyzed in silico.
Like Api g 1, Mal d 1 lacked dominant T-cell epitopes. The degree of surface binding and the kinetics of uptake and endolysosomal degradation of Bet v 1, Api g 1, and Mal d 1 were comparable. Endolysosomal degradation of Bet v 1 and Mal d 1 resulted in very similar fragments. The Bet v 1142-156 and Mal d 1141-155 regions showed no striking difference in their binding affinities to the most frequent HLA-DR alleles.
The sensitizing activity of different Bet v 1 homologs correlates with the presence of immunodominant T-cell epitopes. However, the presence of Bet v 1142-156 is not conferred by differential antigen processing.
Bet v 1是桦树花粉中的主要致敏变应原。与许多其他主要变应原一样,它含有一个免疫显性T细胞激活区(Bet v 1 142 - 156)。芹菜中的Bet v 1同源物Api g 1缺乏致敏能力,且没有主要的T细胞表位。
我们分析了苹果中无致敏性的Bet v 1同源物Mal d 1的T细胞表位,并评估了Bet v 1、Api g 1和Mal d 1在摄取和抗原加工方面可能存在的差异。
为了进行表位定位,用重叠的合成12肽刺激Mal d 1特异性T细胞系。通过流式细胞术比较抗原呈递细胞对Bet v 1、Api g 1和Mal d 1的表面结合、内化和细胞内降解情况。所有蛋白质都用内溶酶体提取物消化,所得肽段通过质谱鉴定。通过计算机模拟分析HLA II类分子对Bet v 1 142 - 156和Mal d 1中同源区域的结合情况。
与Api g 1一样,Mal d 1缺乏显性T细胞表位。Bet v 1、Api g 1和Mal d 1的表面结合程度以及摄取和内溶酶体降解动力学相当。Bet v 1和Mal d 1的内溶酶体降解产生非常相似的片段。Bet v 1 142 - 156和Mal d 1 141 - 155区域与最常见的HLA - DR等位基因的结合亲和力没有显著差异。
不同Bet v 1同源物的致敏活性与免疫显性T细胞表位的存在相关。然而,Bet v 1 142 - 156的存在并非由差异抗原加工所致。